Arctoris progresses a pipeline of wholly-owned and partnered first-in-class and best‑in‑class therapeutics in oncology and neurodegeneration.

Internal and partnered pipeline

Arctoris is a biotech platform company built on robotics, data science, and machine learning. We pursue several ambitious internal discovery programs, partly being jointly developed with select biotech and pharma partners in Joint Ventures and co-development models. Combining our deep medical and scientific expertise with our sector-defining technological capabilities, we are currently actively pursuing seven programs in different oncology and neurodegenerative indications – all designed to become first-in-class or best-in-class molecules addressing an unmet clinical need.

Contact us to learn more about our pipeline and opportunities for licensing, collaboration and partnership.

Therapeutic
area
Patient
population
Target Partnership Target id & validation Hit ID Hit to lead Lead optimization Preclinical
Oncology
Undisclosed
+
AI Partner
Neuro
Dual Target Undisclosed
+
AI Partner
Oncology
Systematic Screen
Oncology
Systematic Screen
Population size
Rare/Orphan
Frequent
TBD